These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27231226)

  • 1. Volumetric Description of Brain Atrophy in Neuronal Ceroid Lipofuscinosis 2: Supratentorial Gray Matter Shows Uniform Disease Progression.
    Löbel U; Sedlacik J; Nickel M; Lezius S; Fiehler J; Nestrasil I; Kohlschütter A; Schulz A
    AJNR Am J Neuroradiol; 2016 Oct; 37(10):1938-1943. PubMed ID: 27231226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker.
    Hochstein JN; Schulz A; Nickel M; Lezius S; Grosser M; Fiehler J; Sedlacik J; Löbel U
    Neuroradiology; 2022 Oct; 64(10):2059-2067. PubMed ID: 35699772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy for CLN2 disease: MRI volumetry shows significantly slower volume loss compared to a natural history cohort.
    Gaur P; Gissen P; Biswas A; Mankad K; Sudhakar S; D'Arco F; Schulz A; Fiehler J; Sedlacik J; Löbel U
    AJNR Am J Neuroradiol; 2024 Jul; ():. PubMed ID: 38977290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease).
    Dyke JP; Sondhi D; Voss HU; Yohay K; Hollmann C; Mancenido D; Kaminsky SM; Heier LA; Rudser KD; Kosofsky B; Casey BJ; Crystal RG; Ballon D
    AJNR Am J Neuroradiol; 2016 Jun; 37(6):1160-9. PubMed ID: 26822727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray Matter Matters: A Longitudinal Magnetic Resonance Voxel-Based Morphometry Study of Primary Progressive Multiple Sclerosis.
    Rothstein TL
    Front Neurol; 2020; 11():581537. PubMed ID: 33281717
    [No Abstract]   [Full Text] [Related]  

  • 7. Global and Widespread Local White Matter Abnormalities in Juvenile Neuronal Ceroid Lipofuscinosis.
    Roine U; Roine TJ; Hakkarainen A; Tokola A; Balk MH; Mannerkoski M; Åberg LE; Lönnqvist T; Autti T
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1349-1354. PubMed ID: 29853519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
    Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
    Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
    Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Brain Volume Measurements in Infantile Neuronal Ceroid Lipofuscinosis.
    Baker EH; Levin SW; Zhang Z; Mukherjee AB
    AJNR Am J Neuroradiol; 2017 Feb; 38(2):376-382. PubMed ID: 27765741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter rather than gray matter damage characterizes essential tremor.
    Pietracupa S; Bologna M; Bharti K; Pasqua G; Tommasin S; Elifani F; Paparella G; Petsas N; Grillea G; Berardelli A; Pantano P
    Eur Radiol; 2019 Dec; 29(12):6634-6642. PubMed ID: 31139970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial MRI findings in the Costa Rican variant of neuronal ceroid-lipofuscinosis.
    Peña JA; Cardozo JJ; Montiel CM; Molina OM; Boustany R
    Pediatr Neurol; 2001 Jul; 25(1):78-80. PubMed ID: 11483403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study.
    Lin X; Blumhardt LD; Constantinescu CS
    Acta Neurol Scand; 2003 Dec; 108(6):401-6. PubMed ID: 14616292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in cortical and subcortical structures of healthy adult brains: A surface-based morphometry study.
    Zheng F; Liu Y; Yuan Z; Gao X; He Y; Liu X; Cui D; Qi R; Chen T; Qiu J
    J Magn Reson Imaging; 2019 Jan; 49(1):152-163. PubMed ID: 29676856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain volumetric MRI study in healthy elderly persons using statistical parametric mapping].
    Miyahira Y; Yu J; Hiramatsu K; Shimazaki Y; Takeda Y
    Seishin Shinkeigaku Zasshi; 2004; 106(2):138-51. PubMed ID: 15052785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural brain alterations of Down's syndrome in early childhood evaluation by DTI and volumetric analyses.
    Gunbey HP; Bilgici MC; Aslan K; Has AC; Ogur MG; Alhan A; Incesu L
    Eur Radiol; 2017 Jul; 27(7):3013-3021. PubMed ID: 27798752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.